Pierogi Therapeutics, Inc

CIK 2139858 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Pierogi Therapeutics, Inc.

Recent SEC filings

FiledFormAccession number
Jun 17, 2026D0002139858-26-000001